In the orthotopic GL261 brain tumor model, D-Rapa improves knockdown of AKT phosphorylation compared to Rapa, while both treatments decrease expression of proliferative marker Ki67 and increase expression of apoptotic marker Caspase 3. Here, TRERF1 is linked to brain neoplasm.